Boston Scientific comes under pressure over allegations it used counterfeit plastic to produce vaginal mesh

^{A 60 Minutes report by CBS has resurfaced claims that medical device giant, Boston Scientific, used counterfeit plastic to produce its vaginal mesh products.}

The report uncovered emails suggesting that Boston Scientific bought counterfeit polypropylene from a supplier in China, so it could continue to produce its devices.

Boston Scientific was previously using a Texas-based subsidiary of Chevron Phillips to buy a brand of polypropylene called Marlex. However, the report indicates that Chevron Phillips cancelled its supply partnership with Boston Scientific, after it became concerned about the use of Marlex within the human body. Chevron Phillips even issued a warning stating Marlex must not be used for permanent implant within the human body.

With its deal with Chevron Phillips cancelled, Boston Scientific estimated that its current supply of Marlex would run out by 2012. The company was worried as the FDA had approved its vaginal mesh products on the basis that it was using Marlex to manufacture the devices.

After a second supplier refused to sell Marlex to Boston Scientific in 2010, the company found a broker in China who could supply it with Marlex. The supplier, Emai Plastic Raw Materials, apparently told Boston Scientific that if had a large supply of Marlex that it had imported from Chevron Phillips.

The 60 Minutes report cites court documents revealing that Boston Scientific management told an employee in China not to tell Emai where the material would be used as “it could scare them away”.

More so, Emai did not have the correct documentation to prove that its material was in fact Marlex. After a number of checks on the bags it had purchased from Emai, alongside confirmation with Chevron Phillips, Boston Scientific found that the bags were fraudulent and that the packaging was fake.

Boston Scientific then tested 11 parameters of the material it had obtained from Emai in comparison to Chevron Phillips’ Marlex. The company found that only two parameters were the same and that four of those were classed as 'very different'. However, the company went on to conclude that the two materials were the same and bought 30 years’ worth of supply from Emai, 60 Minutes state.

The 60 Minutes report features commentary from a number of plastics experts and surgeons who have been involved in the removal of mesh in women.

Plastics engineer, Chris DeArmitt, who researched Boston Scientific for one of the women suing the company, said: “I would say the material they're buying maybe is fine for making a park bench. Maybe it's fine for making a disposable cup. But that's a totally different situation when you're looking at something that will be in the body for 40 or 50 or 60 years. There's a whole different level of analysis and confidence that you need. And I don't see that here".

Boston Scientific responded to the 60 Minutes report, issuing a statement on its website, signed off by chairman and CEO Mike Mahoney and executive vice president Urology and Pelvic Health, Dave Pierce.

“The broadcast resurfaced outdated and previously disproven allegations first made by attorneys in 2016. Our rigorous testing and investigation have shown that the resin currently used in our products matches a formulation from the original U.S. produced resin. This information was also reviewed by the U.S. Food and Drug Administration (FDA) and was part of the basis of its conclusions.

“The show offered a one-sided view and commentary from clinicians and plastic experts involved with litigious actions. It is important to keep in mind that polypropylene-based (plastic) devices have been a mainstay in many medical procedures for more than 50 years, including hernia and tendon repair, sutures, and wound closure. Furthermore, our products meet rigorous internal safety standards, international standards, as well the standards of the FDA and other regulatory bodies.” The company states.